22 results on '"Desideri, Marianna"'
Search Results
2. microRNA-378a-5p iS a novel positive regulator of melanoma progression
3. Semaphorin 5A drives melanoma progression: role of Bcl-2, miR-204 and c-Myb
4. VEGF-induced neoangiogenesis is mediated by NAADP and two-pore channel-2-dependent Ca²⁺ signaling
5. Histone deacetylase inhibitor ITF2357 leads to apoptosis and enhances doxorubicin cytotoxicity in preclinical models of human sarcoma
6. BCL-XL overexpression promotes tumor progression-associated properties
7. Removal of the BH4 Domain from Bcl-2 Protein Triggers an Autophagic Process that Impairs Tumor Growth
8. TLR3 engagement induces IRF-3-dependent apoptosis in androgen-sensitive prostate cancer cells and inhibits tumour growth in vivo
9. The mitogen-activated protein kinase (MAPK) cascade controls phosphatase and tensin homolog (PTEN) expression through multiple mechanisms
10. BH4 domain of bcl-2 protein is required for its proangiogenic function under hypoxic condition
11. Down-regulation of the PTTG1 proto-oncogene contributes to the melanoma suppressive effects of the cyclin-dependent kinase inhibitor PHA-848125
12. miR-211 and MITF modulation by Bcl-2 protein in melanoma cells.
13. Histone deacetylase inhibition synergistically enhances pemetrexed cytotoxicity through induction of apoptosis and autophagy in non-small cell lung cancer.
14. Papillary Carcinoma of the Thyroid: High Expression of COX-2 and Low Expression of KAI-1/CD82 Are Associated with Increased Tumor Invasiveness.
15. LMNA Knock-Down Affects Differentiation and Progression of Human Neuroblastoma Cells.
16. Bcl-2 Regulates HIF-1α Protein Stabilization in Hypoxic Melanoma Cells via the Molecular Chaperone HSP90.
17. Bcl-2 overexpression in melanoma cells increases tumor progression-associated properties and in vivo tumor growth.
18. Semaphorin 5A drives melanoma progression: role of Bcl-2, miR-204 and c-Myb.
19. BCL-XL overexpression promotes tumor progression-associated properties.
20. NAADP-Dependent Ca2+ Signaling Controls Melanoma Progression, Metastatic Dissemination and Neoangiogenesis.
21. Functional activity of CXCL8 receptors, CXCR1 and CXCR2, on human malignant melanoma progression
22. Growth-Inhibitory and Antiangiogenic Activity of the MEK Inhibitor PD0325901 in Malignant Melanoma with or without BRAF Mutations.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.